- Home
- » Tags
- » Potency (pharmacology)
Top View
- Oleic Acid Produces Motor Incoordination and Hypoactivity in Infant Wistar Rats Through GABAA Receptors
- The Clinical Link Between Human Intestinal Microbiota and Systemic Cancer Therapy
- Time Course for the Induction and Maintenance of Tolerance to D9-Tetrahydrocannabinol in Mice
- Foundations in Pharmacokinetics
- Engineering a Long-Acting, Potent GLP-1 Analog for Microstructure-Based Transdermal Delivery
- Guidance for Industry Developing Medical Imaging Drug and Biological Products Part 1: Conducting Safety Assessments
- Current Concepts and Treatments of Schizophrenia
- Glyco-Engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice
- Treatment of Infections Caused by Multidrug-Resistant Gram-Negative
- Potency and Efficacy (Effectiveness) - Therapeutic Index
- Pdf); International Conference on Harmonization, 2012 Comparison of Plasma Profiles Is Shown in Fig
- Chapter 1 General Principles of Drug Action 3
- Epigenetics in Society
- Spero Therapeutics Initiates First Clinical Study of Lead Potentiator Candidate for the Treatment of Multidrug Resistant Gram-Negative Infections
- HST-151 1 PRINCIPLES of PHARMACOKINETICS Learning
- Exploring the Emerging Role of the Microbiome in Cancer Immunotherapy Jessica Fessler1†, Vyara Matson1† and Thomas F
- From Drug Combinations to Epigenetic Editing
- Environmental Chemicals, the Human Microbiome, and Health Risk: a Research Strategy
- New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
- Potency, Selectivity, and Consequences of Nonselectivity of PDE Inhibition
- Prediction of Intracellular Exposure Bridges the Gap Between Target
- The Role of Pharmacokinetics and Pharmacodynamics in Phosphodiesterase-5 Inhibitor Therapy
- Pharmacology, Part 2: Introduction to Pharmacokinetics
- Pharmacokinetics/ADME in Drug Discovery an Example
- Potency-Reduced and Extended Half-Life IL12 Heterodimeric Fc
- Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era
- Murd Enzymes: Some Recent Developments
- Response Curve Slope Helps Predict Therapeutic Potency and Breadth of HIV Broadly Neutralizing Antibodies
- Synthesis and Bio-Evaluation of Natural Butenolides-Acrylate Conjugates
- Influence of Cytochrome P450 Polymorphisms on Drug Therapies: Pharmacogenetic, Pharmacoepigenetic and Clinical Aspects ⁎ Magnus Ingelman-Sundberg A, , Sarah C
- Pharmacogenetics of Antipsychotic-Induced Weight Gain
- Fruitful Decade of Fungal Metabolites As Anti-Diabetic Agents from 2010 to 2019: Emphasis on A-Glucosidase Inhibitors
- Pharmacology/Therapeutics I Block I Handouts – 2017-18
- Tramadol Therapy and CYP2D6 Genotype
- Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP)
- United States Patent (19) 11) Patent Number: 5,750,729 Alexander Et Al
- Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Poten
- Hyperactivity, Decreased Startle Reactivity, and Disrupted Prepulse Inhibition Following Disinhibition of the Rat Ventral Hippoc
- Addictive Potency of Substances
- Effects on Human Gut Microbiota—A Review
- Microbiome-Drug and Xenobiotic Interactions Afr
- Lipid-Lowering Potency and Tolerability of Generic Rosuvastatin
- Introduction to Pharmacokinetics and Pharmacodynamics
- Pharmacology Dynamics Kinetics Genetics Dr Lindsey Ferrie [email protected]
- STATISTICAL ANALYSIS of PHARMACOKINETIC DATA--- BIOEQUIVALENCE STUDY by Qingmin Guo a THESIS Submitted to Michigan State Univers
- Structure-Guided Design Fine-Tunes Pharmacokinetics, Tolerability, and Antitumor Profile of Multispecific Frizzled Antibodies